Neuphoria Therapeutics Inc. (NEUP)
NASDAQ: NEUP · Real-Time Price · USD
2.350
+0.030 (1.29%)
Nov 20, 2026, 4:00 PM EST - Market closed
Neuphoria Therapeutics Market Cap
Neuphoria Therapeutics has a market cap or net worth of $12.72 million as of November 20, 2026. It is the 39,599th most valuable company in the world and the 5,348th biggest in the United States. Its market cap has decreased by 46.50% in one year.
Market Cap
12.72M
Enterprise Value
-6.03M
1-Year Change
-46.50%
Global Rank
Country Rank
#5,348 United States
Category
ChartMarket Cap Chart
Since December 24, 2024, Neuphoria Therapeutics's market cap has increased from $10.79M to $12.72M, an increase of 17.87%. That is a compound annual growth rate of 9.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 12.72M | -39.05% |
| Dec 31, 2025 | 20.86M | 273.80% |
| Dec 31, 2024 | 5.58M | -48.27% |
| Dec 24, 2024 | 10.79M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BeyondSpring | 13.57M |
| Pluri | 13.51M |
| Acumen Pharmaceuticals | 13.49M |
| Tvardi Therapeutics | 13.20M |
| Bolt Biotherapeutics | 12.80M |
| Seres Therapeutics | 12.64M |
| Passage Bio | 12.61M |
| Allarity Therapeutics | 12.49M |